Skip to content

A Clinical Study to Evaluate the Efficacy, Safety and Consumer Perception of a Moisturizing Product

A Clinical Study to Evaluate the Efficacy, Safety and Consumer Perception of a Moisturizing Product - A Clinical Study to Evaluate the Efficacy, Safety and Consumer Perception of a Moisturizing Product

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000047956
Enrollment
35
Registered
2022-06-07
Start date
2022-04-25
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

sensitive skin

Interventions

Apply the test material to the lower leg once a day for 2 weeks.

Sponsors

LION CORPORATION
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: a) Subject is male or female of any ethnicity between 21 to 59 years of age; b) Subject has a Fitzpatrick Skin Type I-IV Subject has self-perceived sensitive skin; d) Subject must feel mild to moderate itch on lower legs due to dryness at least once daily and must feel itch at the time of the first visit/screening and the baseline visit; e) Subject has mild to moderate dryness and redness on lower legs; f) Subject agrees not to shave/wax/remove hair on the lower legs for the conditioning phase and for the duration of the study once enrolled; g) Subject agrees not to wash or wet the test sites after test material application at the Baseline visit until completion of the 24 Hour visit; h) Subject is willing to refrain from the use of washcloths, loofahs, or coarse sponges on lower legs; i) Subject is willing to refrain from tanning and swimming for the duration of the study; j) Subject agrees not to start a new exercise program for the duration of the study; k) Subject agrees to wear clothing that easily allows access to the lower legs at all study visits in order to not rub the lower legs when rolling up the pants; l) Subject agrees not to wear pantyhose at any study visits; m) If subject uses OTC itch relievers, they agree to discontinue use on the lower legs but may continue use on other parts of the body; n) Subject agrees not to introduce any new cosmetic or toiletry products during the study; o) Subject is dependable and able to follow directions as outlined in the protocol; p) Subject is willing to participate in all study evaluations; q) Subject is in generally good health r) Subject agrees to sign a Photography Release Form, providing consent for the capture of digital images for use in relation to this clinical study; s) Subject has completed a HIPAA Authorization Form in conformance with 45 CFR Parts 160 and 164; t) Subjects understands and is willing to sign an Informed Consent Form in conformance with 21 CRF Part 50:

Exclusion criteria

Exclusion criteria: a) Female subject is pregnant, nursing, planning a pregnancy, or not using adequate birth control; b) Subject experiences repeated scratching that may cause raised areas on the skin which may bleed or become inflected due to the intense nature of the itch; c) Subject has hives; d) Subject has dense hair on the lower legs; e) Subject is a regular user of prescription itch relievers; f) Subject has used cosmetic itch relievers on the lower legs within one week prior to study start date; #VALUE! h) Subject has known allergies to cosmetics or toiletry products; i) Subject exhibits sunburn, rashes, scratches, burn marks, etc. on the test sites, or has tattoos or piercings which might interfere with study evaluations; j) Subject exhibits or reports a history of acute or chronic dermatological, medical, and/or physical conditions that would preclude application of the test material and/or could influence the outcome of the study; k) Subject has participated in a clinical study which involved the legs within one week of study initiation; l) Subject has a history of skin cancer, or is currently undergoing treatment for active cancer of any kind; m) Subject has diabetes.

Design outcomes

Primary

MeasureTime frame
Evaluation of itch(VAS method), stratum corneum water content, redness(dermatological assessment) before the application of the test material and after the application of test material for 1 and 2 weeks.

Countries

North America

Contacts

Public ContactAKINORI INOUE

LION CORPORATION Global Development Center

ino-aki@lion.co.jp08012731828

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026